ADMA Biologics Inc NASDAQ NMS - GLOBAL MARKET:ADMA
The leadership team, board of directors, and 10% beneficial owners of ADMA Biologics Inc, reconstructed from SEC insider filings and proxy statements.
Other Reporting Persons
Other Section-16 reporting persons associated with the issuer.
ELMS STEVE
—98,020 sharesGrossman Adam S
—580,957 sharesGrossman Jerrold B
—22,857 sharesGuiheen Lawrence P.
—50,990 sharesKohler Terry
—58,019 shares
Recent Form 4 Activity last 90 days
No insider transactions in the last 90 days.
View all insider tradesMethodology
Officers and directors are derived from SEC Forms 3, 4, and 5 filed by reporting persons for this issuer. The roster reflects the most recent disclosed relationship per individual. Officer titles use the issuer-supplied designation from the relationship record.
Independence flags and board committee assignments are sourced from the most recent DEF 14A proxy statement when available. For executive compensation context — base salary, equity grants, performance metrics — refer to the Summary Compensation Table in the issuer's annual proxy.
Cross-references: where a reporting person is matched to a consolidated people profile (same CIK across multiple issuers), the person link routes to the unified profile page so you can see every board seat and officer role in one place.